Oncology & Cancer

Molecular profiling may improve meningioma decision making

Investigators have demonstrated how molecular profiling tumors can be used to help predict treatment response and survival in patients with meningiomas, the most common type of primary brain tumor, according to a recent study ...

Oncology & Cancer

Immunotherapy delays disease progression of high-grade meningiomas

Meningiomas, tumors of the membranes (meninges) surrounding the brain and spinal cord, are the most common tumors of the central nervous system. Although most meningiomas are low grade and cause few or no symptoms, a subset, ...

Oncology & Cancer

Meningioma molecular profile reliably predicts tumor recurrence

Although typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The current meningioma classification does not consistently predict whether the tumor ...

page 1 from 4